POS-264 PATIENT PALATABILITY AND PREFERENCE STUDY OF 3 POTASSIUM BINDERS IN PATIENTS WITH CHRONIC KIDNEY DISEASE AND HYPERKALAEMIA: RATIONALE AND DESIGN OF THE APPETIZE STUDY

Hyperkalaemia (HK) is a potentially fatal condition often seen in patients with chronic kidney disease (CKD) and is associated with a higher risk of cardiovascular events and mortality. Traditional potassium (K+) binders used to treat HK are poorly tolerated by patients and associated with gastrointestinal side effects. Recently approved K+ binders can provide new treatment options which are more palatable and better tolerated to fulfil this unmet need.